HPC The Hydration Pharmaceuticals Company Limited

—Mkt Cap: —P/E: —

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. It sells its …

Key Statistics

Company
Market Cap—
Enterprise Value809.29K USD
Revenue (TTM)1.49M USD
Gross Profit942.53K USD
Net Income (TTM)-1.98M USD
Revenue/Share0.0050 AUD
Last Price—
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryAU
SectorConsumer Defensive
IndustryPersonal Care
ISINAU0000187957
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue0.54
P/S0.75
P/B2.09
EPS (TTM)-0.01
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin55.18%
Oper. Margin-102.28%
EBITDA Margin0.00%
Profit Margin-115.74%
ROE-201.64%
ROA-130.45%
Growth
Revenue Growth-21.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.05M USD
CapEx (TTM)—
FCF Margin-59.41%
FCF Yield—
Net Debt-306.09K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio2.13
Quick Ratio0.90
Book Value/Sh0.0014 AUD
Cash/Share0.0010 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.537.99M
Float219.60M
Insiders55.58%
Institutions21.28%
Technical
SMA 500.0034 AUD
SMA 2000.0041 AUD
Beta0.92
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)71.34K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—